Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Bahrain Minister Hails UKGulf Trade Deal as Monumental Achievement for Both Sides Data Centre Expansion in Chile Exacerbates Water Scarcity Threatening Tech Hub Ambitions Emerging Assets Rally as USIran Peace Hopes Buoy Investor Sentiment EU New Car Market 2026 Electric Vehicle Growth and Chinese Carmaker Expansion Highlighted by ACEA Data Early Signs of AI Job Disruption Emerge in Latest Employment Data Leonardo DRS Inc DRS Q1 2026 Earnings EPS Surges Past Estimates as Defense Demand Remains Robust DDL Q4 2025 Earnings Profitability Highlight as EPS Reported at 041 ESP Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Performance HCA Q1 2026 Earnings EPS Slightly Misses Estimates Amid Steady Demand Biohaven Ltd BHVN Q1 2026 Earnings Wider Loss Than Expected as PreRevenue Biotech Advances Pipeline National Fuel Gas Co NFG Slips Slightly as Trading Consolidates Near Key Support Levels BioMarin Pharmaceutical BMRN Holds Steady Near Support as Investors Evaluate Pipeline Progress Global Water Resources Inc GWRS Surges 7 Support Holding Resistance in View Stifel Financial SF Holds Steady Near 7255 as Market Sentiment Remains Cautious Trump Tower Tbilisi Project Faces Scrutiny Over Land Ownership Linked to Sanctioned Leaders Son South East Water Service Outage Raises Regulatory and Operational Concerns Venture Global Reports Record Q1 2026 Results Amid Rising LNG Demand Dropbox CEO Drew Houston Steps Down After 19 Years Transitioning to Executive Chairman Wingstop Inc WING Rallies 585 as Shares Test Key Resistance Xcel Energy Holds Steady Near 8078 as Utility Sector Navigates Mixed Signals Eagle Capital Growth Fund GRF Slips 119 Approaches Key Support at 95 Hayward Holdings Inc HAYW Gains Momentum Key Levels and What Lies Ahead Exagen Inc XGN Inches Lower as Shares Test Key Support Near 405 Jasper Therapeutics JSPR Hovers Near Support as Biotech Sentiment Remains Cautious